Shilin Xu
- Molecular Biology
- Oncology top 10%
- Organic Chemistry top 10%
- Pulmonary and Respiratory Medicine
- Hematology top 10%
- Topics
- Protein Degradation and Inhibitors (8 papers)Ubiquitin and proteasome pathways (6 papers)Cancer therapeutics and mechanisms (6 papers)
- Cited by
- OncologyMolecular BiologyHematology
- Journals
- Angewandte Chemie International EditionSHILAP Revista de lepidopterologíaJournal of Hazardous Materials
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Shilin Xu
65 papers receiving 997 citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 538
- Oncology 265
- Organic Chemistry 155
- Pulmonary and Respiratory Medicine 125
- Hematology 86
Countries citing papers authored by Shilin Xu
This map shows the geographic impact of Shilin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilin Xu more than expected).
Fields of papers citing papers by Shilin Xu
This network shows the impact of papers produced by Shilin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilin Xu. The network helps show where Shilin Xu may publish in the future.
Co-authorship network of co-authors of Shilin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shilin Xu. A scholar is included among the top collaborators of Shilin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilin Xu. Shilin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 7 | |
| 9 | 13 | |
| 10 | 7 | |
| 11 | 4 | |
| 12 | 28 | |
| 13 | 9 | |
| 14 | 7 | |
| 15 | 6 | |
| 16 | 19 | |
| 17 | 8 | |
| 18 | 3 | |
| 19 | 128 | |
| 20 | 51 |
About Shilin Xu
Shilin Xu is a scholar working on Biological Psychiatry, Hematology and Oncology, having authored 69 papers that have together received 1.0k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (265 citations), Molecular Biology (538 citations) and Hematology (86 citations). Shilin Xu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Hongping Chen, Yuyang Tian, Lumei Kang, Xiaomei Ren, Lianwen Zhang, Yingxue Liu, Tianfeng Xu, Ke Ding, Zhang Zhang and Shaomeng Wang. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.